Frontage Laboratories Executive and Leadership Team

November, 2026

Leadership Overview

Frontage Laboratories has 5 executives leading key functions including corporate strategy, operational excellence, financial oversight, and international market expansion.

Committed to accelerating drug development, Frontage Laboratories delivers integrated, science-driven solutions that empower pharmaceutical and biotechnology partners to achieve critical regulatory milestones across global markets.

Leadership Roles at Frontage Laboratories

  • Co-Chief Executive Officer - Daniella Kranjac
  • Co-Chief Executive Officer - Zhongping Lin
  • Interim Chief Financial Officer - Huan Wang
  • Chief Operating Officer - Min Wang
  • Executive Vice President of Frontage International and President of China - Yining Qi
  • Daniella Kranjac - Co-Chief Executive Officer

    Daniella Kranjac, the Co-Chief Executive Officer at Frontage Laboratories, directs the overarching corporate strategy and long-term growth initiatives. Focusing on the expansion of integrated drug development services, Kranjac aligns internal capabilities with the evolving needs of biotechnology clients. This leadership role involves cultivating strategic partnerships and ensuring the delivery of high-quality analytical testing and formulation development services. By overseeing the integration of preclinical and clinical trial material manufacturing, Daniella Kranjac drives operational excellence across the organization. The Co-Chief Executive Officer maintains a sharp focus on market positioning, ensuring that the company remains a preferred partner for pharmaceutical firms navigating complex drug discovery processes. Through rigorous oversight of business development, the executive secures the necessary resources to advance diverse molecules through development cycles, ultimately supporting the successful filing of regulatory submissions in the United States, China, and other international territories.

    Zhongping Lin - Co-Chief Executive Officer

    Zhongping Lin, the Co-Chief Executive Officer at Frontage Laboratories, architects the scientific vision and technical framework for the company's comprehensive service offerings. Concentrating on drug metabolism, pharmacokinetics, and bioanalysis, Lin ensures that all laboratory operations meet the highest standards of scientific rigor. This leadership role involves guiding the technical teams through complex preclinical safety and toxicology assessments to facilitate seamless transitions into early phase clinical studies. Zhongping Lin monitors the efficacy of research methodologies, ensuring that data integrity remains at the forefront of every project. By fostering a culture of innovation, the Co-Chief Executive Officer enables the organization to solve intricate development challenges for biotechnology clients. Through constant evaluation of scientific advancements, Lin maintains the company's competitive edge in the global CRO landscape, ensuring that all research outputs support robust regulatory filings and accelerate the path to market for life-saving pharmaceutical products.

    Huan Wang - Interim Chief Financial Officer

    Huan Wang, the Interim Chief Financial Officer at Frontage Laboratories, governs the financial health and fiscal strategy of the organization. Managing capital allocation, budgeting, and financial reporting, Wang ensures that the company maintains the necessary liquidity to support ongoing investments in drug discovery and development services. This leadership role involves analyzing the financial impact of preclinical and clinical trial material manufacturing projects to ensure long-term profitability. Huan Wang collaborates with the executive team to evaluate potential growth opportunities and assess the financial risks associated with international market expansion. By overseeing the financial planning process, the Interim Chief Financial Officer provides the data-driven insights required for strategic decision-making. The executive maintains rigorous internal controls and financial transparency, ensuring that the company remains well-positioned to fund its mission of enabling biotechnology and pharmaceutical companies to achieve their development goals through sustainable financial practices.

    Min Wang - Chief Operating Officer

    Min Wang, the Chief Operating Officer at Frontage Laboratories, manages the daily execution of integrated service delivery across all laboratory and clinical facilities. Overseeing the synchronization of analytical testing, formulation development, and manufacturing workflows, Wang ensures maximum efficiency and adherence to project timelines. This leadership role involves optimizing resource allocation to support the diverse requirements of pharmaceutical and biotechnology clients. Min Wang implements standardized operational protocols that enhance productivity while maintaining strict compliance with global regulatory standards. By coordinating cross-functional teams, the Chief Operating Officer facilitates the smooth progression of molecules through the drug development pipeline. The executive monitors operational performance metrics to identify opportunities for process improvement and capacity expansion. Through the diligent management of internal infrastructure and service delivery systems, Wang ensures that the company consistently meets the complex demands of the drug discovery process, ultimately driving successful outcomes for partners worldwide.

    Yining Qi - Executive Vice President of Frontage International and President of China

    Yining Qi, the Executive Vice President of Frontage International and President of China at Frontage Laboratories, directs the company's strategic expansion and operational footprint within the Asian market. Overseeing the integration of local research capabilities with global service standards, Qi ensures that clients in China receive the same high-quality drug metabolism, bioanalysis, and clinical trial support as those in other regions. This leadership role involves navigating the complex regulatory landscape to facilitate successful submissions for international pharmaceutical partners. Yining Qi manages regional teams to ensure that all preclinical and clinical activities align with the company's broader mission of accelerating drug development. By fostering strong relationships with local stakeholders and regulatory bodies, the executive drives the growth of the company's presence in the region. Through the effective management of regional operations, the Executive Vice President of Frontage International and President of China secures the company's position as a critical partner in the global drug development ecosystem.

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Frontage Laboratories Top Executives and Leadership Team

    Who leads Frontage Laboratories?
    Frontage Laboratories is led by Daniella Kranjac (Co-Chief Executive Officer), along with executives such as Zhongping Lin (Co-Chief Executive Officer) and Huan Wang (Interim Chief Financial Officer).
    Who is part of Frontage Laboratories’s executive team?
    The executive team of Frontage Laboratories includes leaders such as Daniella Kranjac (Co-Chief Executive Officer), Zhongping Lin (Co-Chief Executive Officer), Huan Wang (Interim Chief Financial Officer) and other senior executives.
    How many executives does Frontage Laboratories have?
    Frontage Laboratories has 5 executives leading key business areas.
    What roles are included in Frontage Laboratories’s leadership team?
    The leadership team of Frontage Laboratories includes roles such as Co-Chief Executive Officer, Co-Chief Executive Officer, Interim Chief Financial Officer, Chief Operating Officer, Executive Vice President of Frontage International and President of China.